Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 5/20 | 1.00 |
| ▸ | MAOB | P27338 | 4/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | HPGD | P15428 | 1/20 | 0.67 |
| ▸ | CA12 | O43570 | 3/20 | 0.66 |
| ▸ | CA1 | P00915 | 3/20 | 0.66 |
| ▸ | CA9 | Q16790 | 3/20 | 0.66 |
| ▸ | CA3 | P07451 | 2/20 | 0.66 |
| ▸ | CA4 | P22748 | 2/20 | 0.66 |
| ▸ | CA6 | P23280 | 2/20 | 0.66 |
| ▸ | CA5A | P35218 | 2/20 | 0.66 |
| ▸ | CA7 | P43166 | 2/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.66 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.66 |
| ▸ | CA2 | P00918 | 2/20 | 0.66 |
| ▸ | GPR35 | Q9HC97 | 8/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11344142 | 0.98 | MAOA (0.97) | MAOAMAOBALDH1A1LMNAHPGD | |
| SCHEMBL1367029 | 0.88 | MAOA (0.79) | MAOAMAOBALDH1A1LMNAHPGD | |
| SCHEMBL11344137 | 0.85 | MAOA (0.73) | MAOAMAOBALDH1A1LMNAHPGD | |
| SCHEMBL980080 | 0.83 | MAOA (0.71) | MAOAMAOBALDH1A1LMNAHPGD | |
| SCHEMBL31315657 | 0.83 | MAOA (0.71) | MAOAMAOBALDH1A1LMNAHPGD | |
| SCHEMBL31315660 | 0.83 | MAOA (0.71) | MAOAMAOBALDH1A1LMNAHPGD | |
| SCHEMBL980248 | 0.83 | MAOA (0.71) | MAOAMAOBALDH1A1LMNAHPGD | |
| SCHEMBL11341006 | 0.83 | MAOA (0.71) | MAOAMAOBALDH1A1LMNAHPGD | |
| SCHEMBL31315659 | 0.83 | MAOA (0.71) | MAOAMAOBALDH1A1LMNAHPGD | |
| SCHEMBL18306420 | 0.83 | MAOA (0.71) | MAOAMAOBALDH1A1LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111285790-A | 3-carboxycoumarin derivative capable of serving as GPR35 agonist, preparation method and application | 泰州医药城国科化物生物医药科技有限公司 | 2020-06-16 | — | — | CN | claimed |
| WO-2020114290-A1 | 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION | 泰州医药城国科化物生物医药科技有限公司 | 2020-06-11 | — | — | WO | claimed |
| CN-112939916-B | Method for synthesizing coumarin-3-carboxylic acid compounds by one-pot two-step method | 河南中烟工业有限责任公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-113024499-A | Green synthesis method of coumarin-3-carboxylic acid compounds | 河南中烟工业有限责任公司 | 2021-06-25 | — | — | CN | disclosed |
| CN-112939916-A | Method for synthesizing coumarin-3-carboxylic acid compounds by one-pot two-step method | 河南中烟工业有限责任公司 | 2021-06-11 | — | — | CN | disclosed |
| CN-108715589-B | Coumarin derivative used as caspase-3 activator and application thereof | 华侨大学 | 2021-04-20 | — | — | CN | disclosed |
| CN-111285790-A | 3-carboxycoumarin derivative capable of serving as GPR35 agonist, preparation method and application | 泰州医药城国科化物生物医药科技有限公司 | 2020-06-16 | — | — | CN | disclosed |
| WO-2020114290-A1 | 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION | 泰州医药城国科化物生物医药科技有限公司 | 2020-06-11 | — | — | WO | disclosed |
| WO-2020114290-A1 | 3-CARBOXYL COUMARIN DERIVATIVE CAPABLE OF BEING USED AS A GPR35 AGONIST, PREPARATION METHOD, AND APPLICATION | 泰州医药城国科化物生物医药科技有限公司 | 2020-06-11 | — | — | WO | disclosed |
| CN-108715589-A | A kind of coumarin derivatives and its application as caspase-3 activator | 华侨大学 | 2018-10-30 | — | — | CN | disclosed |
| US-8642788-B2 | Activators of executioner procaspases 3, 6 and 7 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-02-04 | — | — | US | disclosed |
| CN-101965189-A | Activators of pro-caspase 3, 6 and 7 | UNIV CALIFORNIA | 2011-02-02 | — | — | CN | disclosed |
| US-20110021522-A1 | ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-01-27 | — | — | US | disclosed |
| EP-2237784-A1 | ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 | The Regents of the University of California (US) | 2010-10-13 | — | — | EP | disclosed |
| WO-2009089508-A1 | ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-07-16 | — | — | WO | disclosed |
| US-4303664-A | Novel penicillin derivatives containing a coumarin nucleus and medicines containing the same | TEIJIN LIMITED (JP) | 1981-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021522-A1 | ACTIVATORS OF EXECUTIONER PROCASPASES 3, 6 AND 7 | CASP7, CASP3, CASP6 | MAOA 2101/4885MAOB 3235/4885ALDH1A1 2806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.